Updated time: 2023-09-28 10:20:24
Kawasaki disease (KD) is the leading cause of acquired heart disease in children. Delay of diagnosis could increase the risk of heart complication. To date, KD diagnosis relies on the clinical features in the suspected children with persisting fever over 5 days. This invention has extremely high sensitivity and specificity for KD diagnosis in the acute stage of the disease and is useful for early diagnosis (fever less than 4 days). Another application of this invention is monitoring the efficacy of Intravenous immunoglobulin (IVIG) treatment. Although the mortality rate due to KD is low, the heart complication caused by KD is irreversible. Early diagnosis will allow the early initiation of the treatment which can reduce the heart complication. The invention can be applicable for all children who clinically are suspected of having KD
- At present time, there is no reliable lab test for KD.
- To date, comparing with known plasma biomarkers of KD, this invention has the best sensitivity and specificity.
- Comparing with other types of biomarkers in KD (eg. biomarker in urine or RNA transcript in blood), this invention has relative higher stability and more convenient.
- There are existing patients who are resistant to current KD therapy (eg. IVIG or anti-TNF-α). This invention provides novel targets or therapeutic avenue in the treatment of KD.
12A-1020605
TW I598586、TW I655433、CN 106796221 B、 US 10,983,133B2、JP 特許6779200、KR 10-2453756、 CA 2,955,214
- Facilitate the early diagnosis of KD (fever within 5 days)。
- A reliable method for KD diagnosis in the acute stage of KD (fever over 5 days)。Because this invention has extremely high discrimination between KD cases and non-KD cases, it is a highly reliable detection method for objective diagnosis. Furthermore, it has highly potential to differ iKD (incomplete KD) from non-KD cases with KD clinical features.
- Evaluation of IVIG therapeutic efficacy in KD.
- Novel therapeutic targets in KD.
Yuan-Tsong Chen, Jer-Yuan Wu, Tai-Ming Ko, Ho-Chang Kuo, Jeng-Sheng Chang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Method of diagnosing and treating KAWASAKI disease